In severe asthma with an eosinophilic phenotype, depemokimab improved exacerbations, but not quality of life, at 52 wk

Ann Intern Med. 2025 Jan;178(1):JC8. doi: 10.7326/ANNALS-24-03437-JC. Epub 2025 Jan 7.

Authors

Christine F McDonald¹; ACP Journal Club Editorial Team at McMaster University

Affiliation

¹ Austin Hospital and University of Melbourne, Melbourne, Victoria, Australia (C.F.M.).

PMID: 39761576
DOI: 10.7326/ANNALS-24-03437-JC

Abstract

GIM/FP/GP: [Formula: see text] Allerg & Immunol: [Formula: see text] Pulmonology: [Formula: see text].

Publication types

Editorial